These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25469484)

  • 21. Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?
    Cuthbert JJ; Pellicori P; Rigby AS; Abel AAI; Kalvickbacka-Bennet A; Shah P; Kearsley JW; Kazmi S; Cleland JGF; Clark AL
    Eur Heart J Qual Care Clin Outcomes; 2023 Apr; 9(3):281-292. PubMed ID: 35723241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure.
    Du JB; Da CH; Zhao Y; Guo Y; Guo G; Ju TF; Xu YP
    Acta Cardiol; 2012 Jun; 67(3):291-6. PubMed ID: 22870736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study.
    Hudson SR; Chan D; Ng LL
    J R Soc Med; 2016 Sep; 109(9):337-46. PubMed ID: 27609799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
    Fu S; Xie L; Li D; Ye P; Luo L
    Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine.
    Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B
    Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).
    Anand IS; Fisher LD; Chiang YT; Latini R; Masson S; Maggioni AP; Glazer RD; Tognoni G; Cohn JN;
    Circulation; 2003 Mar; 107(9):1278-83. PubMed ID: 12628948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congestion and nutrition as determinants of bioelectrical phase angle in heart failure.
    Scicchitano P; Ciccone MM; Passantino A; Valle R; De Palo M; Sasanelli P; Sanasi M; Piscopo A; Guida P; Caldarola P; Massari F
    Heart Lung; 2020; 49(6):724-728. PubMed ID: 32871396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure.
    Tsutamoto T; Asai S; Tanaka T; Sakai H; Nishiyama K; Fujii M; Yamamoto T; Ohnishi M; Wada A; Saito Y; Horie M
    Eur J Heart Fail; 2007 Oct; 9(10):1032-7. PubMed ID: 17766177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuresis-Related Weight Loss Reflects Interstitial Compartment Decongestion with Minimal Impact on Intravascular Volume Expansion or Outcomes in Post-Acute Heart Failure: Metrics of Decongestion and Volume Status.
    Miller WL; Lobo R; Grill DE; Mullan BP
    J Card Fail; 2021 Apr; 27(4):445-452. PubMed ID: 33347996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies.
    Kobayashi M; Rossignol P; Ferreira JP; Aragão I; Paku Y; Iwasaki Y; Watanabe M; Fudim M; Duarte K; Zannad F; Girerd N
    Clin Res Cardiol; 2019 May; 108(5):549-561. PubMed ID: 30341579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visit-to-Visit B-Type Natriuretic Peptide Variability during the Previous Year Has Independent Prognostic Value in Patients with Stable Chronic Heart Failure.
    Kagiyama N; Yuri T; Hayashida A; Hirohata A; Yamamoto K; Yoshida K
    Cardiology; 2019; 143(3-4):92-99. PubMed ID: 31330506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
    Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole body bioimpedance monitoring for outpatient chronic heart failure follow up.
    Tanino Y; Shite J; Paredes OL; Shinke T; Ogasawara D; Sawada T; Kawamori H; Miyoshi N; Kato H; Yoshino N; Hirata K
    Circ J; 2009 Jun; 73(6):1074-9. PubMed ID: 19372625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma sestrin2 concentrations in patients with chronic heart failure and predicted the occurrence of major adverse cardiac events: A 36-month follow-up cohort study.
    Wang H; Li N; Shao X; Li J; Guo L; Yu X; Sun Y; Hao J; Niu H; Xiang J; Li X; Han X
    Clin Chim Acta; 2019 Aug; 495():338-344. PubMed ID: 31059702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.